Journal
NEUROBIOLOGY OF DISEASE
Volume 143, Issue -, Pages -Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2020.105014
Keywords
Sphingolipids; Ceramides; Ceramide synthase; Neurological diseases; Neurodegenerative disorders
Categories
Funding
- Spanish Institute for Health Carlos III [PI17/00916]
- European Regional Development Fund FEDER, a way to build Europe
- Hesperia Foundation
- Autonomous Government of Catalonia AGAUR [2017SGR1206]
- CIBERER ACCI [ER20P2AC759/2020]
Ask authors/readers for more resources
In recent years, research on sphingolipids, particularly ceramides, has attracted increased attention, revealing the important roles and many functions of these molecules in several human neurological disorders. The nervous system is enriched with important classes of sphingolipids, e.g., ceramide and its derivatives, which compose the major portion of this group, particularly in the form of myelin. Ceramides have also emerged as important nodes for lipid signalling, both inside the cell and between cells. Until recently, knowledge about ceramides in the nervous system was limited, but currently, multiple links between ceramide signalling and neurological diseases have been reported. Alterations in the regulation of ceramide pathobiology have been shown to influence the risk of developing neurometabolic diseases. Thus, these molecules are critically important in the maintenance and development of the nervous system and are culprits or major contributors to the development of brain disorders, either inherited or multifactorial. In the present review, we highlight the critical role of ceramide signalling in several different neurological disorders as well as the effects of their perturbations and discuss how this emerging class of bioactive sphingolipids has attracted interest in the field of neurological diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available